Dolon Ltd
Katja Jürgenschellert is a seasoned professional in market access strategy, currently serving as a Senior Consultant at Dolon Ltd since March 2021. Jürgenschellert's expertise has been developed through various roles, including prior positions at Accenture as an Analyst in Digital Health and as a Consultant. A strong academic foundation includes a Master of Science in International Health Policy from the London School of Economics and Political Science and a Bachelor of Business Administration from Hanze University. Jürgenschellert also has experience as a Market Access Consultant at Roche, where analytical skills and project coordination were honed. Additional roles as a Research Assistant at the LSE Department of Health Policy and various management and strategic positions demonstrate a comprehensive background in both healthcare and business strategy.
This person is not in any teams
This person is not in any offices
Dolon Ltd
Dolon is a leading, strategic consultancy specialising in pricing and market access for rare disease medicines. We partner and provide strategic guidance to global and national pharmaceutical companies on a variety of market access and policy issues globally. Our goal is to ensure that effective rare disease treatments are made accessible to the patients who need them, in a way that is sustainable for both the pharmaceutical industry and society. Our market access specialists deliver solutions at a therapy, disease, portfolio and industry level to realise success throughout the product life cycle. We provide services in the following areas: • Value, Price and Access • Market Access Policy • Data and Analytics Headquartered in London, and with offices globally, we are a team of enthusiastic and intellectually curious individuals who share a passion for collaboration and solving complex problems.